• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Complete Financial Solutions Inc
Lightspeed Commerce Inc. Subordinate Voting Shares
Strikeforce Technologies Inc
Xalles Holdings Inc
iTonic Holdings Ltd - Class A Ordinary Shares
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Puma Biotechnology Inc - Common Stock (NQ:PBYI)

9.830 -0.690 (-6.56%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 406,600
Open 10.51
Bid (Size) 9.630 (100)
Ask (Size) 10.27 (1,000)
Prev. Close 10.52
Today's Range 9.810 - 10.51
52wk Range 4.575 - 10.72
Shares Outstanding 47,509,765
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
October 05, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
September 17, 2026
From Puma Biotechnology, Inc.
Via Business Wire

Performance

52-Week Range 8.3% below 52-week high
9.830
4.5852W Low 10.7252W High
1 Week 8.3% below 1-week high
9.811W Low 10.721W High

Puma Biotechnology Inc - Common Stock (PBYI) traded between $4.58 and $10.72 over the past 52 weeks and last traded at $9.83, 8.3% below its 52-week high. Over the past week it ranged between $9.81 and $10.72.

Past 12 Months
-4.5%
+3.3%
+18.4%
+33.4%
+70.4%
+79.7%
1W -$0.46
1M +$0.31
3M +$1.53
6M +$2.46
YTD +$4.06
1Y +$4.36

PBYI was +79.7% over the past year, +33.4% over six months, +70.4% year to date, -4.5% in the last week.

12 Months vs Market
PBYI
+79.7%
DIA
+12.4%
SPY
+14.9%
QQQ
+17.5%
IWM
+11.1%

Over the past 12 months PBYI returned +79.7% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 1.27× 3-mo avg
Today 406,600 3-mo avg 320.9K
1W
338.3K
1M
341.0K
3M
320.9K
6M
309.2K
YTD
341.1K
1Y
373.0K

PBYI most recently traded 406,600 shares against a 3-month average daily volume of 320.9K.

More News

Read More
News headline image
Puma Biotechnology to Present at H.C. Wainwright’s 28th Annual Global Investment Conference
September 09, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 03, 2026
From Puma Biotechnology, Inc.
Via Business Wire
Puma Biotechnology (NASDAQ:PBYI) Beats Q2 Estimates, but Soft Q3 Guidance Tempers Reaction ↗
August 06, 2026
Via Chartmill
PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) Beats Q1 Estimates, Raises Full-Year Guidance ↗
May 07, 2026
Via Chartmill
Puma Biotechnology (NASDAQ:PBYI) Beats Q4 Estimates, Guides for Profitable 2026 ↗
February 26, 2026
Via Chartmill
News headline image
Puma Biotechnology (PBYI) Q2 2026 Earnings Call Transcript ↗
August 14, 2026
Via The Motley Fool
Topics Earnings
News headline image
Puma Biotechnology Q2 Earnings Call Highlights ↗
August 07, 2026
Via MarketBeat
Topics Earnings
News headline image
Puma Biotechnology Reports Second Quarter 2026 Financial Results
August 06, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 05, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results
July 23, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
July 02, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma (PBYI) Q1 2026 Earnings Call Transcript ↗
May 08, 2026
Via The Motley Fool
Topics Earnings
News headline image
Puma Biotechnology Q1 Earnings Call Highlights ↗
May 08, 2026
Via MarketBeat
Topics Earnings
News headline image
Puma Biotechnology Reports First Quarter 2026 Financial Results
May 07, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
May 06, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
April 23, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 02, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? ↗
March 23, 2026
Via The Motley Fool
News headline image
Puma Biotech (PBYI) Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
February 26, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference
February 23, 2026
From Puma Biotechnology, Inc.
Via Business Wire
News headline image
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
From Puma Biotechnology, Inc.
Via Business Wire

Frequently Asked Questions

Is Puma Biotechnology Inc - Common Stock publicly traded?
Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
What exchange does Puma Biotechnology Inc - Common Stock trade on?
Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
What is the current price of Puma Biotechnology Inc - Common Stock?
The current price of Puma Biotechnology Inc - Common Stock is 9.830
When was Puma Biotechnology Inc - Common Stock last traded?
The last trade of Puma Biotechnology Inc - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of Puma Biotechnology Inc - Common Stock?
The market capitalization of Puma Biotechnology Inc - Common Stock is 467.02M
How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
Puma Biotechnology Inc - Common Stock has 467M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap